Liquid purification or separation – Processes – Liquid/liquid solvent or colloidal extraction or diffusing...
Patent
1994-03-21
1996-01-23
Kim, John
Liquid purification or separation
Processes
Liquid/liquid solvent or colloidal extraction or diffusing...
210656, 530413, 530417, B01D 1500, B01D 1508
Patent
active
054862930
ABSTRACT:
Novel sorbents and methods for removing small hydrophobic and amphophilic molecules from biological fluids were disclosed. The methods and materials were particularly useful for removing viral inactivating agents from blood and blood fractions. The novel sorbents comprise a porous mineral oxide matrix having its interior porous volume substantially filled with a crosslinked hydrophobic polymer network.
REFERENCES:
patent: 4481189 (1984-11-01), Prince
patent: 4540573 (1985-09-01), Neurath et al.
patent: 4615886 (1986-10-01), Purcell et al.
patent: 4720385 (1988-01-01), Lembach
patent: 4764369 (1988-08-01), Neurath et al.
patent: 4841023 (1989-06-01), Horowitz
patent: 4857514 (1989-08-01), Lippa et al.
patent: 4939176 (1990-07-01), Seng et al.
patent: 5053135 (1991-10-01), Boschetti et al.
patent: 5151499 (1992-09-01), Kameyama et al.
patent: 5186945 (1993-02-01), Shanbrom
patent: 5204324 (1993-04-01), Shanbrom
patent: 5268097 (1993-12-01), Girot et al.
Prince et al. "Inactivation of Hepatitis B and Hutchinson Strain Non-A, Non-B Hepatitis Viruses . . . " Vox Sang 46, 36-43 (1984).
Prince et al. "Quantitative Assays for Evaluation of HTLV-III Inactivation . . . " Cancer Research 45, 4592s-4594s (1985).
Prince et al. "Sterilisation of Hepatitis and HTLV-III Viruses by Exposure to . . . " The Lancet, Mar. 29, 1986, pp. 706-709.
Horowitz et al. "Inactivation of viruses in labile blood derivatives" Transfusion 25, 516-522 (1985).
Edwards et al. "Tri (n-Butyl) Phosphate/Detergent Treatment of Licensed Therapeutic . . . " Vox Sang 52, 53-59 (1987).
Horowitz et al. "Inactivation of Lipid-Enveloped Viruses in Labile Blood Derivatives . . . " Vox Sang 54, 14-20 (1988).
Horowitz et al. "Solvent/Detergent-Treated Plasma: A Virus-Inactivated Substitute . . . " Blood 79, 3, 826-831 (1992).
DiPaolantonio, et al. "Low Risk of Transmission of the Human Immunodeficiency . . . " J. Med. Virology 36, 71-74 (1992).
Piquet et al. "Virus Inactivation of Fresh Frozen Plasma by a Solvent Detergent Procedure: . . . " Vox Sang 63, 251-256 (1992).
Michalski et al. "Large-Scale Production and Properties of a Solvent-Detergent-Treated . . . " Vox Sang 55, 202-210 (1988).
Strancar et al. "Extraction of Triton X-100 and its determination in virus-inactivated . . . " J. Chrom. A. 658, 475-481 (1994).
L. Guerrier et al., Journal of Chromatography B: Biomedical Applications, 664, pp. 119-125 (1995).
Boschetti Egisto
Girot Pierre
Guerrier Luc P.
Hemasure Inc.
Kim John
LandOfFree
Removal of small exogenous molecules from biological fluids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Removal of small exogenous molecules from biological fluids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Removal of small exogenous molecules from biological fluids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1503170